Oncologic outcome of robot-assisted laparoscopic prostatectomy in the high-risk setting

Jason D. Engel, William W. Kao, Stephen Williams, Y. Mark Hong

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background and Purpose: Previous studies have demonstrated the feasibility of open radical prostatectomy in the high-risk setting. Management of high-risk disease with robot-assisted laparoscopic radical prostatectomy (RALP) is controversial. We examined biochemical recurrence in a selected cohort of high-risk patients who were undergoing RALP. Patients and Methods: Men with high-risk prostate cancer who underwent bilateral nerve-sparing, nonsalvage RALP by a single surgeon without adjuvant or neoadjuvant therapy of any kind were identified. High risk was defined by preoperative prostate-specific antigen (PSA) level >10ng/dL, Gleason score ≥8 on final pathologic evaluation, or stage ≥pT3. Postoperative PSA value ≥0.2ng/dL defined biochemical recurrence. Results: A total of 73 men were identified. There was no significant difference in surgical margin positivity (38% overall) or prostate size between recurrence and nonrecurrence cohorts. Biochemical failure was significantly associated with higher pathologic Gleason score (P=0.0085) but not pathologic stage (P=0.22) or preoperative PSA level (P=0.18). With follow-up to 85 months (mean 31.8 mos), biochemical recurrence-free survival was 77% with mean time to recurrence of 7.7 months. Recurrence occurred significantly earlier than later (P

Original languageEnglish (US)
Pages (from-to)1963-1966
Number of pages4
JournalJournal of Endourology
Volume24
Issue number12
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Prostatectomy
Recurrence
Prostate-Specific Antigen
Neoplasm Grading
Neoadjuvant Therapy
Risk Management
Prostate
Prostatic Neoplasms
Survival

ASJC Scopus subject areas

  • Urology

Cite this

Oncologic outcome of robot-assisted laparoscopic prostatectomy in the high-risk setting. / Engel, Jason D.; Kao, William W.; Williams, Stephen; Hong, Y. Mark.

In: Journal of Endourology, Vol. 24, No. 12, 01.12.2010, p. 1963-1966.

Research output: Contribution to journalArticle

Engel, Jason D. ; Kao, William W. ; Williams, Stephen ; Hong, Y. Mark. / Oncologic outcome of robot-assisted laparoscopic prostatectomy in the high-risk setting. In: Journal of Endourology. 2010 ; Vol. 24, No. 12. pp. 1963-1966.
@article{58a21aef5b694a8c976f579a09d6a085,
title = "Oncologic outcome of robot-assisted laparoscopic prostatectomy in the high-risk setting",
abstract = "Background and Purpose: Previous studies have demonstrated the feasibility of open radical prostatectomy in the high-risk setting. Management of high-risk disease with robot-assisted laparoscopic radical prostatectomy (RALP) is controversial. We examined biochemical recurrence in a selected cohort of high-risk patients who were undergoing RALP. Patients and Methods: Men with high-risk prostate cancer who underwent bilateral nerve-sparing, nonsalvage RALP by a single surgeon without adjuvant or neoadjuvant therapy of any kind were identified. High risk was defined by preoperative prostate-specific antigen (PSA) level >10ng/dL, Gleason score ≥8 on final pathologic evaluation, or stage ≥pT3. Postoperative PSA value ≥0.2ng/dL defined biochemical recurrence. Results: A total of 73 men were identified. There was no significant difference in surgical margin positivity (38{\%} overall) or prostate size between recurrence and nonrecurrence cohorts. Biochemical failure was significantly associated with higher pathologic Gleason score (P=0.0085) but not pathologic stage (P=0.22) or preoperative PSA level (P=0.18). With follow-up to 85 months (mean 31.8 mos), biochemical recurrence-free survival was 77{\%} with mean time to recurrence of 7.7 months. Recurrence occurred significantly earlier than later (P",
author = "Engel, {Jason D.} and Kao, {William W.} and Stephen Williams and Hong, {Y. Mark}",
year = "2010",
month = "12",
day = "1",
doi = "10.1089/end.2010.0305",
language = "English (US)",
volume = "24",
pages = "1963--1966",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - Oncologic outcome of robot-assisted laparoscopic prostatectomy in the high-risk setting

AU - Engel, Jason D.

AU - Kao, William W.

AU - Williams, Stephen

AU - Hong, Y. Mark

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Background and Purpose: Previous studies have demonstrated the feasibility of open radical prostatectomy in the high-risk setting. Management of high-risk disease with robot-assisted laparoscopic radical prostatectomy (RALP) is controversial. We examined biochemical recurrence in a selected cohort of high-risk patients who were undergoing RALP. Patients and Methods: Men with high-risk prostate cancer who underwent bilateral nerve-sparing, nonsalvage RALP by a single surgeon without adjuvant or neoadjuvant therapy of any kind were identified. High risk was defined by preoperative prostate-specific antigen (PSA) level >10ng/dL, Gleason score ≥8 on final pathologic evaluation, or stage ≥pT3. Postoperative PSA value ≥0.2ng/dL defined biochemical recurrence. Results: A total of 73 men were identified. There was no significant difference in surgical margin positivity (38% overall) or prostate size between recurrence and nonrecurrence cohorts. Biochemical failure was significantly associated with higher pathologic Gleason score (P=0.0085) but not pathologic stage (P=0.22) or preoperative PSA level (P=0.18). With follow-up to 85 months (mean 31.8 mos), biochemical recurrence-free survival was 77% with mean time to recurrence of 7.7 months. Recurrence occurred significantly earlier than later (P

AB - Background and Purpose: Previous studies have demonstrated the feasibility of open radical prostatectomy in the high-risk setting. Management of high-risk disease with robot-assisted laparoscopic radical prostatectomy (RALP) is controversial. We examined biochemical recurrence in a selected cohort of high-risk patients who were undergoing RALP. Patients and Methods: Men with high-risk prostate cancer who underwent bilateral nerve-sparing, nonsalvage RALP by a single surgeon without adjuvant or neoadjuvant therapy of any kind were identified. High risk was defined by preoperative prostate-specific antigen (PSA) level >10ng/dL, Gleason score ≥8 on final pathologic evaluation, or stage ≥pT3. Postoperative PSA value ≥0.2ng/dL defined biochemical recurrence. Results: A total of 73 men were identified. There was no significant difference in surgical margin positivity (38% overall) or prostate size between recurrence and nonrecurrence cohorts. Biochemical failure was significantly associated with higher pathologic Gleason score (P=0.0085) but not pathologic stage (P=0.22) or preoperative PSA level (P=0.18). With follow-up to 85 months (mean 31.8 mos), biochemical recurrence-free survival was 77% with mean time to recurrence of 7.7 months. Recurrence occurred significantly earlier than later (P

UR - http://www.scopus.com/inward/record.url?scp=78650288492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650288492&partnerID=8YFLogxK

U2 - 10.1089/end.2010.0305

DO - 10.1089/end.2010.0305

M3 - Article

VL - 24

SP - 1963

EP - 1966

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 12

ER -